MAPK8 and hepatocellular carcinoma: As shown in Figure 8H–8J, compared with negative control, the migration and invasion of HCC cells transfected with si-THRSP or si-NC were inhibited after being treated with BAY-11-7082 (NF-κB inhibitor), AG-126 (ERK1/2 inhibitor), SB203580 (p38 MAPK inhibitor) and SP600125 (JNK inhibitor).